ApprovalTrail

Approval · Notice of Compliance 17782 · 2016

CILOXAN: Notice of Compliance 17782

Issued February 17, 2016

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
17782
Date
February 17, 2016
Company
Alcon Canada Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Removal of otic indication

Products in this notice

BrandDINStatus today
CILOXANNot yet assigned—

Medicinal ingredients